INVESTOR RELATIONS CENTER

Tern PLC

News Detail

DGAP-UK-Regulatory News vom 26.03.2019

Tern PLC: New commercial order for FundamentalVR

Tern PLC (TERN)

26-March-2019 / 10:10 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


26 March 2019

Tern Plc ("Tern" or the "Company")

New commercial order for FundamentalVR

Tern Plc (AIM: TERN), the investment company specialising in the Internet of Things ("IoT"), is pleased to announce that FVRVS Limited ("FundamentalVR"), a leading Virtual Reality ("VR") training and data analysis technology platform and one of its existing portfolio companies, has secured an initial order of £150,000 to create a VR simulation, for one of the world's leading pharmaceutical companies.

FundamentalVR's award winning platform combines immersive virtual reality with cutting-edge haptics (the sense of touch) to create low-cost and scalable simulation experiences to offer a new way to allow skills development for surgeons and medical professionals.  

The project is the first in a planned series of VR experiences that FundamentalVR's client is commissioning to inform, educate and measure awareness and compliant, safe use of their pharma products. This first implementation will teach the method of action and the patient experience of a pharmaceutical product.

This multi-stage VR approach is expected to become a template for future product launches by the pharmaceutical client, which are intended to utilise FundamentalVR's virtual reality with haptics platform.

Tern CEO, Al Sisto, said, "This is a new approach to pharma and medical device product introductions, which we believe will accelerate the adoption of new medical products in building out the use procedures in a repeatable practice scenario were the individual's performance can be measured against a standard and his/her peers. FundamentalVR and its customers share the belief that the comparative data insights and measurements collected and available through the FundamentalVR platform will have a profoundly positive impact on medical outcomes and products around the world".

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

**ENDS**

Enquiries

Tern plc

Al Sisto, CEO

Sarah Payne, Finance Director

 

Via Newgate Communications

 

Allenby Capital Limited

(Nomad and Joint broker)

David Worlidge/Alex Brearley

 

Tel: 0203 328 5656

 

Whitman Howard

(Joint broker)

Nick Lovering/Christopher Furness

 

Tel: 020 7659 1234

Newgate Communications

PR

Elisabeth Cowell/Fiona Norman

Tel: 020 3757 6880

 




show this
Diese Inhalte werden Ihnen präsentiert von der .